Thank you for Subscribing to Life Science Review Weekly Brief
Mark Bainbridge will strengthen Inceptua’s business development team and drive growth to Inceptua Early Access’ exclusive distribution business.
FREMONT, CA: “The opportunity to recruit such a senior expert in this field as Mark is fantastic news for Inceptua, and we are planning on further strengthening our BD team by the end of the year,” states Jeremy Broadis, Chief Business Officer, Inceptua Group. Inceptua has hired Mark Bainbridge as a Senior Director of Business Development. Mark has substantial early access expertise, having held top positions at Idis/Clinigen and Parexel. Mark will be located in Inceptuas' New York office and will focus on pharmaceutical and biotech firms in the United States.
Mark Bainbridge has been employed by Inceptua Early Access, a division of global pharmaceutical business and service partner Inceptua Group, to assist the company's sustained growth in the early access area.
Mark will be in charge of driving forward Inceptua Early Access' exclusive distribution business in addition to his early access business development responsibilities.
“Since becoming operational a little over three years ago, the Early Access business unit has seen substantial year-on-year growth, with much of that growth originating through personal networks and referrals. With the foundations of the business unit now fully established the time is right to drive forward with our long-term strategy and cement our position as a leader in the early access space, offering a unique approach and unmatched expertise to support companies as they seek to bring their medicines to patients as quickly as possible,” adds Broadis.